BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16611632)

  • 1. Functional consequences of a mutation in an expressed human alpha-cardiac actin at a site implicated in familial hypertrophic cardiomyopathy.
    Bookwalter CS; Trybus KM
    J Biol Chem; 2006 Jun; 281(24):16777-84. PubMed ID: 16611632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do cardiac actin mutations lead to altered actomyosin interactions?
    Dahari M; Dawson JF
    Biochem Cell Biol; 2015 Aug; 93(4):330-4. PubMed ID: 26194323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways.
    Deng Y; Schmidtmann A; Kruse S; Filatov V; Heilmeyer LM; Jaquet K; Thieleczek R
    J Mol Cell Cardiol; 2003 Nov; 35(11):1365-74. PubMed ID: 14596793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro.
    Debold EP; Saber W; Cheema Y; Bookwalter CS; Trybus KM; Warshaw DM; Vanburen P
    J Mol Cell Cardiol; 2010 Feb; 48(2):286-92. PubMed ID: 19799913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immediate effect of HCM causing actin mutants E99K and A230V on actin-Tm-myosin interaction in thin-filament reconstituted myocardium.
    Bai F; Caster HM; Dawson JF; Kawai M
    J Mol Cell Cardiol; 2015 Feb; 79():123-32. PubMed ID: 25451174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
    Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G
    J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro rescue study of a malignant familial hypertrophic cardiomyopathy phenotype by pseudo-phosphorylation of myosin regulatory light chain.
    Muthu P; Liang J; Schmidt W; Moore JR; Szczesna-Cordary D
    Arch Biochem Biophys; 2014 Jun; 552-553():29-39. PubMed ID: 24374283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy.
    Müller M; Mazur AJ; Behrmann E; Diensthuber RP; Radke MB; Qu Z; Littwitz C; Raunser S; Schoenenberger CA; Manstein DJ; Mannherz HG
    Cell Mol Life Sci; 2012 Oct; 69(20):3457-79. PubMed ID: 22643837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
    Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome.
    Sata M; Ikebe M
    J Clin Invest; 1996 Dec; 98(12):2866-73. PubMed ID: 8981935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilated cardiomyopathy mutation in the converter domain of human cardiac myosin alters motor activity and response to omecamtiv mecarbil.
    Tang W; Unrath WC; Desetty R; Yengo CM
    J Biol Chem; 2019 Nov; 294(46):17314-17325. PubMed ID: 31578282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M-class hypertrophic cardiomyopathy cardiac actin mutations increase calcium sensitivity of regulated thin filaments.
    Teng GZ; Shaikh Z; Liu H; Dawson JF
    Biochem Biophys Res Commun; 2019 Oct; 519(1):148-152. PubMed ID: 31481237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Failure to Communicate: MYOSIN RESIDUES INVOLVED IN HYPERTROPHIC CARDIOMYOPATHY AFFECT INTER-DOMAIN INTERACTION.
    Kronert WA; Melkani GC; Melkani A; Bernstein SI
    J Biol Chem; 2015 Dec; 290(49):29270-80. PubMed ID: 26446785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actomyosin kinetics and in vitro motility of wild-type Drosophila actin and the effects of two mutations in the Act88F gene.
    Anson M; Drummond DR; Geeves MA; Hennessey ES; Ritchie MD; Sparrow JC
    Biophys J; 1995 May; 68(5):1991-2003. PubMed ID: 7612841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers.
    Hernandez OM; Szczesna-Cordary D; Knollmann BC; Miller T; Bell M; Zhao J; Sirenko SG; Diaz Z; Guzman G; Xu Y; Wang Y; Kerrick WG; Potter JD
    J Biol Chem; 2005 Nov; 280(44):37183-94. PubMed ID: 16115869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.
    Roopnarine O; Leinwand LA
    Biophys J; 1998 Dec; 75(6):3023-30. PubMed ID: 9826622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional studies of yeast actin mutants corresponding to human cardiomyopathy mutations.
    Wong WW; Doyle TC; Cheung P; Olson TM; Reisler E
    J Muscle Res Cell Motil; 2001; 22(8):665-74. PubMed ID: 12222827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties.
    Keller DI; Coirault C; Rau T; Cheav T; Weyand M; Amann K; Lecarpentier Y; Richard P; Eschenhagen T; Carrier L
    J Mol Cell Cardiol; 2004 Mar; 36(3):355-62. PubMed ID: 15010274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.